Skip to content
Catholic Online Logo

By Catholic Online (NEWS CONSORTIUM)

11/2/2012 (1 year ago)

Catholic Online (www.catholic.org)

Alemtuzumab is used most frequently in cancer, leukemia patients

Alemtuzumab is a new drug is the "most effective" treatment for relapsing-remitting multiple sclerosis. Researchers at the University of Cambridge say that alemtuzumab, a cancer drug, which wipes out and resets the immune system, has better results than other options. The down side? There is new concern that the drugs company that manufactures the medication is about to increase the cost of the drug as a result.

'There is concern that with a license for multiple sclerosis, the cost of alemtuzumab could rise and might become too expensive for many patients and health systems,' an editorial in the medical journal the Lancet warns.

"There is concern that with a license for multiple sclerosis, the cost of alemtuzumab could rise and might become too expensive for many patients and health systems," an editorial in the medical journal the Lancet warns.

Highlights

By Catholic Online (NEWS CONSORTIUM)

Catholic Online (www.catholic.org)

11/2/2012 (1 year ago)

Published in Health

Keywords: Alemtuzumab, multiple sclerosis, leukemia, cancer, price hike


LOS ANGELES, CA (Catholic Online) - Around 100,000 people in the United Kingdom have multiple sclerosis. When the condition is diagnosed, the majority will have a form of the disease know as relapsing-remitting MS. In this strain of the condition, the symptoms can almost disappear for a time, before suddenly returning.

Alemtuzumab has shown benefits for MS in small studies. Typically used for leukemia patients, a blood cancer, controls the excess production of white blood cells. In MS patients, the dose eliminates the immune cells entirely, forcing a new immune system to be built from scratch which should not attack the nerves.

Two test trials compared the effectiveness of alemtuzumab with a first-choice drug, interferon beta-1a.

One compared the effectiveness in patients given the drug after being diagnosed, the other looked at patients given the drug after other treatments had failed.

Both showed the drug was around 50 percent more effective at preventing relapses and patients had less disability at the end of the study than when they started.

"Although other MS drugs have emerged over the last year, which is certainly good news for patients, none has shown superior effects on disability when compared to interferon except alemtuzumab," Dr. Alasdair Coles, from the University of Cambridge says.

"It is certainly the most effective MS drug, based on these clinical trials, but this is definitely not a cure," he told reporters from the BBC.

The doctor warns that there were side-effects, including developing other immune disorders.

He said he thought the drug would be most useful for patients for whom standard treatment had failed and in a "minority" of patients as a first-choice drug.

The drug has been withdrawn from the market in both Europe and the United States as the manufacturer, Genzyme, intends to have it licensed as a treatment for MS.

"There is concern that with a license for multiple sclerosis, the cost of alemtuzumab could rise and might become too expensive for many patients and health systems," an editorial in the medical journal the Lancet warns.

"Finding promising treatments such as alemtuzumab are important. But so is keeping alemtuzumab accessible and affordable."

.

---


Pope Francis: end world hunger through 'Prayer and Action'


© 2014 - Distributed by THE NEWS CONSORTIUM

Pope Francis Prayer Intentions for August 2014
Refugees:
That refugees, forced by violence to abandon their homes, may find a generous welcome and the protection of their rights.
Oceania: That Christians in Oceania may joyfully announce the faith to all the people of that region.



Comments


More Health

Do you eat pomegranates? Well here's a few reasons why you should Watch

Image of Pomegranates contain the chemical punicalagin, a form of a chemical compound known as polyphenol, which may help to prevent the inflammation that destroys brain cells known as micrologia.

By Catholic Online (NEWS CONSORTIUM)

An ingredient in pomegranate may help stop the spread of Alzheimer's disease, scientists from the University of Huddersfield claim. LOS ANGELES, CA (Catholic Online) - The chemical punicalagin, a form of a chemical compound known as polyphenol, helps prevent the ... continue reading


NEW HOPE IN EBOLA CRISIS: U.S. doctor released from hospital - cured Watch

Image of

By Catholic Online (NEWS CONSORTIUM)

Contracting the deadly African virus while he worked to save their lives, Dr. Kent Brantly became one of the handful of people from the United States to contract Ebola. Receiving treatment back in the U.S., Brantly walked out of the hospital to the waiting arms ... continue reading


HEALTH DISASTER: Is nearly half of all Americans destined to contract diabetes? Watch

Image of The irony of the situation is that Americans are generally living longer, which is a factor in their increased lifetime chance of developing type 2 diabetes. Americans are also not dying in the same proportions that they were, because of better treatment.

By Catholic Online (NEWS CONSORTIUM)

Has the United States reached the tipping point with diabetes and obesity? A shocking new study claims that nearly HALF of all Americans, if trends continue, will develop type 2 diabetes in the near future. Public Health England, in their most recent report ... continue reading


First large-scale shipment of new malaria drug shipped out Watch

Image of The recent shipment marks a new phase in the fight against the mosquito-borne disease.

By Catholic Online (NEWS CONSORTIUM)

Just as virulent - as far more easily transmitted than Ebola, malaria is making new inroads to populations in sub-Saharan Africa. In response, French drug maker Sanofi has announced the delivery of large-scale batches of an antimalarial drug made using ... continue reading


Very accurate colon cancer in-home detection kit approved by FDA Watch

Image of  The U.S. Food and Drug Administration has approved a new at-home, DNA-based stool test that screens for colorectal cancer with more than 90 percent accuracy.

By Catholic Online (NEWS CONSORTIUM)

Screening for colon cancer is frequently arduous and invasive. Patients need to fast prior to a colonoscopy, and the colonoscopy itself be highly uncomfortable and not always accurate. There's now good news for those at risk. The U.S. Food and Drug ... continue reading


You'll think twice before you put this dangerous chemical back in your mouth! Watch

Image of Colgate's Total brand of toothpaste contains the chemical triclosan, which has been proven to cause disruptions in the endocrine system in mice and rats.

By Catholic Online (NEWS CONSORTIUM)

A top-selling toothpaste uses the chemical triclosan which has been linked to cancer-cell growth and disrupted development in animals, and regulators are still reviewing whether or not it's safe to pt in soap, cutting boars and toys, while many consumer companies ... continue reading


New diabetes drug could help us all: Found effective in preventing cancer Watch

Image of Scientists who studied more than 180,000 people found a

By Catholic Online (NEWS CONSORTIUM)

According to a new study, a drug widely prescribed to treat type 2 diabetes could help us all live longer. Said drug, metformin, which controls glucose levels, may also stave off cardiovascular disease and cancer, regardless if the person is diabetic. LOS ... continue reading


Mutated gene increases women's chance for breast cancer by threefold Watch

Image of Doctors also could recommend more aggressive surveillance for breast cancer, such as annual mammograms or MRI breast screening.

By Catholic Online (NEWS CONSORTIUM)

A new study has found that mutated versions of a gene called PALB2 can dramatically increase a woman's risk of breast cancer. Researchers say that women carrying the PALB2 mutation have a one in three chance of developing breast cancer by the age of 70. LOS ... continue reading


WAS WORLD'S THROAT CUT? Ebola vaccine research was earlier abandoned Watch

Image of It must also be noted that while the National Institutes of Health and the U.S. government often fund the early animal safety and efficacy testing of a vaccine, pharmaceutical companies typically fund the human clinical trials to take a drug or vaccine to market.

By Catholic Online (NEWS CONSORTIUM)

With increasing fears of the Ebola virus in West Africa and elsewhere, world governments are now frantically trying to contain the disease. What is not widely known is the fact that there had been work on finding a vaccine for Ebola four years ago, that was ... continue reading


PLAGUE STRIKES HOME: At least six people tested for Ebola in U.S. Watch

Image of Said individual, who has recently traveled to West Africa where the current outbreak is taking place is said to be under

By Catholic Online (NEWS CONSORTIUM)

At least six people within the continental United States have been tested for the dreaded Ebola virus, the deadly hemorrhagic disease tearing through West Africa. While all six people tested negative, the states in which these people were from remains a tightly ... continue reading


All Health News

Newsletters

Newsletter Sign Up icon

Stay up to date with the latest news, information, and special offers

Daily Readings

Reading 1, First Corinthians 2:10-16
10 to us, though, God has given revelation through ... Read More

Psalm, Psalms 145:8-9, 10-11, 12-13, 13-14
8 Yahweh is tenderness and pity, slow to anger, full ... Read More

Gospel, Luke 4:31-37
31 He went down to Capernaum, a town in Galilee, and ... Read More

Saint of the Day

Saint of the Day for September 2nd, 2014 Image

St. Ingrid of Sweden
September 2: Born in Skänninge, Sweden, in the 13th century, St. Ingrid lived ... Read More

Inform, Inspire & Ignite Logo

Find Catholic Online on Facebook and get updates right in your live feed.

Become a fan of Catholic Online on Facebook


Follow Catholic Online on Twitter and get News and Product updates.

Follow us on Twitter